Wird geladen...
Spiromax, a New Dry Powder Inhaler: Dose Consistency under Simulated Real-World Conditions
Background: Spiromax(®) is a novel dry powder inhaler for patients with asthma or chronic obstructive pulmonary disease (COPD). The studies presented here provide further data on attributes (in vitro dosing consistency with budesonide–formoterol (DuoResp) Spiromax; flow rates through empty versions...
Gespeichert in:
| Veröffentlicht in: | J Aerosol Med Pulm Drug Deliv |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Mary Ann Liebert, Inc.
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4601554/ https://ncbi.nlm.nih.gov/pubmed/26352860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jamp.2015.1216 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|